{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:03:42Z","timestamp":1787587422880,"version":"build-2736575974"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Abbott Diagnostics and BioPorto Diagnostics provided NGAL reagents, calibrators"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Acute kidney injury (AKI), a frequent and serious complication of hospitalized patients, is associated with increased mortality and morbidity. Neutrophil gelatinase-associated lipocalin (NGAL) is a biomarker for the early identification of AKI. We report a comparative laboratory verification of the Abbott Diagnostics (ARCHITECT\u00ae urine NGAL) and BioPorto Diagnostics (NGAL TestTM) assays including an assessment of the Abbott assay\u2019s performance in EDTA plasma.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Intra-\/interbatch imprecision, linearity, recovery, and limit of quantitation (LoQ) were assessed and an interassay comparison performed (n\u2009=\u200951). Between-laboratory agreement was assessed against other laboratories using the Abbott (n\u2009=\u200948) and BioPorto (n\u2009=\u200994) assays. Plasma NGAL (pNGAL) levels were measured in non-AKI patients with a range of estimated glomerular filtration rates (n\u2009=\u200980).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Coefficients of variation (CVs) for intra- and interbatch imprecision were 0.7%\u201312.4% and 1.9%\u201327.5% for the BioPorto assay, respectively, and 1.4%\u20136.3%\/3.4%\u20136.8%, respectively, for the Abbott assay. The BioPorto assay exhibited a higher LoQ (27.5\u2009ng\/mL vs 1.2\u2009ng\/mL). Both assays were linear over the range 5\u20136000\u2009ng\/mL. Recovery of recombinant NGAL was 113.1\u2009\u00b1\u20097.1% and 96.5\u2009\u00b1\u20097.8% for the Abbott and BioPorto assays, respectively. On average, the Abbott assay gave results 9.2% lower than the BioPorto assay. Mean differences of 0.2% (Abbott) and 20.2% (BioPorto) were observed in the between-laboratory comparison. In patients without AKI, pNGAL levels were inversely proportional to eGFR.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Performance of the Abbott and BioPorto assays was similar although the latter performed less well at lower NGAL concentrations. The Abbott assay tended to yield lower results, exhibited a lower LoQ and over-recovered NGAL. Although only Conformit\u00e9 Europ\u00e9enne-marked and marketed for use in urine, the Abbott assay demonstrated equivalent performance to the BioPorto assay with EDTA plasma.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jalm\/jfab167","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T12:16:32Z","timestamp":1636114592000},"page":"747-761","source":"Crossref","is-referenced-by-count":7,"title":["Comparative Evaluation of Two NGAL Automated Immunoassays in Urine and Plasma"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3119-2696","authenticated-orcid":false,"given":"Simon J","family":"Whitehead","sequence":"first","affiliation":[{"name":"Department of Blood Sciences, Royal Wolverhampton NHS Trust, New Cross Hospital, Wolverhampton, West Midlands, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Chadwick","sequence":"additional","affiliation":[{"name":"Department of Blood Sciences, Royal Wolverhampton NHS Trust, New Cross Hospital, Wolverhampton, West Midlands, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Ford","sequence":"additional","affiliation":[{"name":"Department of Blood Sciences, Royal Wolverhampton NHS Trust, New Cross Hospital, Wolverhampton, West Midlands, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Giri","sequence":"additional","affiliation":[{"name":"Department of Cardiac Anesthesia, Royal Wolverhampton NHS Trust, New Cross Hospital, Wolverhampton, West Midlands, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heyman","family":"Luckraz","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Royal Wolverhampton NHS Trust, New Cross Hospital, Wolverhampton, West Midlands, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rousseau","family":"Gama","sequence":"additional","affiliation":[{"name":"Department of Blood Sciences, Royal Wolverhampton NHS Trust, New Cross Hospital, Wolverhampton, West Midlands, UK"},{"name":"School of Medicine and Clinical Practice, Wolverhampton University, Wolverhampton, West Midlands, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,1,5]]},"reference":[{"key":"2022050518545356200_jfab167-B1","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.ajkd.2009.07.020","article-title":"Accuracy of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis","volume":"54","author":"Haase","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"2022050518545356200_jfab167-B2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1053\/ajkd.2002.34505","article-title":"Long-term outcomes in acute renal failure patients treated with continuous renal replacement therapies","volume":"40","author":"Morgera","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"2022050518545356200_jfab167-B3","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1681\/ASN.2004090740","article-title":"Acute kidney injury, mortality, length of stay, and costs in hospitalized patients","volume":"16","author":"Chertow","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"2022050518545356200_jfab167-B4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41581-018-0052-0","article-title":"Global epidemiology and outcomes of acute kidney injury","volume":"14","author":"Hoste","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"2022050518545356200_jfab167-B5"},{"key":"2022050518545356200_jfab167-B6","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/ndt\/gfu060","article-title":"The cost of ignoring acute kidney injury","volume":"29","author":"Lewington","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"2022050518545356200_jfab167-B7","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/ki.2011.379","article-title":"Chronic kidney disease after acute kidney injury: a systematic review","volume":"81","author":"Coca","year":"2012","journal-title":"Kidney Int"},{"key":"2022050518545356200_jfab167-B8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13054-019-2314-z","article-title":"The aftermath of acute kidney injury: a narrative of long-term mortality and renal function","volume":"23","author":"de Geus","year":"2019","journal-title":"Crit Care"},{"key":"2022050518545356200_jfab167-B9","first-page":"153","article-title":"Acute kidney injury: diagnostic approaches and controversies","volume":"37","author":"Makris","year":"2016","journal-title":"Clin Biochem Rev"},{"key":"2022050518545356200_jfab167-B10","article-title":"Acute kidney injury: prevention, detection and management","volume":"148","year":"2019","journal-title":"NICE Guideline"},{"issue":"Suppl 2","key":"2022050518545356200_jfab167-B11","first-page":"1","article-title":"KDIGO clinical practice guideline for acute kidney injury","year":"2012","journal-title":"Kidney International"},{"key":"2022050518545356200_jfab167-B12","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute renal failure\u2013definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) group","volume":"8","author":"Bellomo","year":"2004","journal-title":"Crit Care"},{"key":"2022050518545356200_jfab167-B13","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"key":"2022050518545356200_jfab167-B14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/cc7759","article-title":"Clinical review: RIFLE and AKIN \u2013 time for reappraisal","volume":"13","author":"Cruz","year":"2009","journal-title":"Crit Care"},{"key":"2022050518545356200_jfab167-B15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1258\/acb.2009.009249","article-title":"Acute kidney injury: how do we define it?","volume":"47","author":"Lewington","year":"2010","journal-title":"Ann Clin Biochem"},{"key":"2022050518545356200_jfab167-B16","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1111\/j.1751-7133.2010.00163.x","article-title":"Early biomarkers of renal injury","volume":"16","author":"Cruz","year":"2010","journal-title":"Congest Heart Fail"},{"key":"2022050518545356200_jfab167-B17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000227785","article-title":"Early diagnosis of acute kidney injury: the promise of novel biomarkers","volume":"28","author":"Soni","year":"2009","journal-title":"Blood Purif"},{"key":"2022050518545356200_jfab167-B18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2217\/bmm.10.12","article-title":"Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury","volume":"4","author":"Devarajan","year":"2010","journal-title":"Biomark Med"},{"key":"2022050518545356200_jfab167-B19","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/sj.ki.5002743","article-title":"The RIFLE criteria and mortality in acute kidney injury: a systematic review","volume":"73","author":"Ricci","year":"2008","journal-title":"Kidney Int"},{"key":"2022050518545356200_jfab167-B20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000437237","article-title":"Genomic and proteomic characterization of acute kidney injury","volume":"131","author":") Devarajan","year":"2015","journal-title":"Nephron"},{"key":"2022050518545356200_jfab167-B21","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2215\/CJN.04010907","article-title":"Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study","volume":"3","author":"Bennett","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022050518545356200_jfab167-B22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/FJC.0b013e31819d6139","article-title":"Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass","volume":"53","author":"Tuladhar","year":"2009","journal-title":"J Cardiovasc Pharmacol"},{"key":"2022050518545356200_jfab167-B23","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.jacc.2010.11.051","article-title":"The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies","volume":"57","author":"Haase","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2022050518545356200_jfab167-B24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/0004563214521795","article-title":"Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury: a critical evaluation of current status","volume":"51","author":"Haase-Fielitz","year":"2014","journal-title":"Ann Clin Biochem"},{"key":"2022050518545356200_jfab167-B25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1515\/cclm-2015-0464","article-title":"A comparison of three commercial platforms for urinary NGAL in critically ill adults","volume":"54","author":"Cruz","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"2022050518545356200_jfab167-B26","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1258\/acb.2012.012117","article-title":"A comparison of the analytical performance of five commercially available assays for neutrophil gelatinase-associated lipocalin using urine","volume":"50","author":"Kift","year":"2013","journal-title":"Ann Clin Biochem"},{"key":"2022050518545356200_jfab167-B27","doi-asserted-by":"crossref","first-page":"6630","DOI":"10.4049\/jimmunol.171.12.6630","article-title":"Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNF-alpha","volume":"171","author":"Cowland","year":"2003","journal-title":"J Immunol"},{"key":"2022050518545356200_jfab167-B28","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/gut.38.3.414","article-title":"Induction of NGAL synthesis in epithelial cell human colorectal neoplasia and inflammatory bowel diseases","volume":"38","author":"Nielsen","year":"1996","journal-title":"Gut"},{"key":"2022050518545356200_jfab167-B29","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(05)74811-X","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery","volume":"365","author":"Mishra","year":"2005","journal-title":"Lancet"},{"key":"2022050518545356200_jfab167-B30","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/CCM.0b013e318195846e","article-title":"Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery\u2014a prospective cohort study","volume":"37","author":"Haase-Fielitz","year":"2009","journal-title":"Crit Care Med"},{"key":"2022050518545356200_jfab167-B31","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/CCM.0b013e318169245a","article-title":"Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock","volume":"36","author":"Wheeler","year":"2008","journal-title":"Crit Care Med"},{"key":"2022050518545356200_jfab167-B32","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.athoracsur.2014.10.011","article-title":"Neutrophil gelatinase-associated lipocalin as early predictor of acute kidney injury after cardiac surgery in adults with chronic kidney failure","volume":"99","author":"Perrotti","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"2022050518545356200_jfab167-B33","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00000542-200609000-00011","article-title":"Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery","volume":"105","author":"Wagener","year":"2006","journal-title":"Anesthesiology"},{"key":"2022050518545356200_jfab167-B34","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1186\/cc6089","article-title":"Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study","volume":"11","author":"Zappitelli","year":"2007","journal-title":"Crit Care"},{"key":"2022050518545356200_jfab167-B35","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1681\/ASN.2010080796","article-title":"Biological markers of acute kidney injury","volume":"22","author":"Siew","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2022050518545356200_jfab167-B36","article-title":"Tests to help assess risk of acute kidney injury for people being considered for critical care admission (ARCHITECT and Alinity i Urine NGAL assays, BioPorto NGAL Test and NephroCheck Test)","volume":"39.","year":"2020","journal-title":". NICE Diagnostics Guidance"},{"key":"2022050518545356200_jfab167-B37","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1172\/JCI23056","article-title":"Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury","volume":"115","author":"Mori","year":"2005","journal-title":"J Clin Invest"},{"key":"2022050518545356200_jfab167-B38","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.clinbiochem.2015.08.003","article-title":"Evaluation of a particle enhanced turbidimetric assay for the measurement of neutrophil gelatinase-associated lipocalin in plasma and urine on Architect-8000: analytical performance and establishment of reference values","volume":"48","author":"Makris","year":"2015","journal-title":"Clin Biochem"},{"key":"2022050518545356200_jfab167-B39","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3109\/00365513.2013.855943","article-title":"Evaluation of NGAL TestTM on Cobas 6000","volume":"74","author":"Hansen","year":"2014","journal-title":"Scand J Clin Lab Invest"},{"key":"2022050518545356200_jfab167-B40","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3109\/00365513.2010.486868","article-title":"Neutrophil Gelatinase-Associated Lipocalin (NGAL): validation of commercially available ELISA","volume":"70","author":"Pedersen","year":"2010","journal-title":"Scand J Clin Lab Invest"},{"key":"2022050518545356200_jfab167-B41","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.clinbiochem.2009.12.008","article-title":"Evaluation of the ARCHITECT urine NGAL assay: Assay performance, specimen handling requirements and biological variability","volume":"43","author":"Grenier","year":"2010","journal-title":"Clin Biochem"},{"key":"2022050518545356200_jfab167-B42","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1515\/cclm.2011.839","article-title":"Evaluation of NGAL Test \u2122, a fully-automated neutrophil gelatinase-associated lipocalin (NGAL) immunoassay on Beckman Coulter AU 5822","volume":"50","author":"Lippi","year":"2012","journal-title":"Clin Chem Lab Med"},{"key":"2022050518545356200_jfab167-B43","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.clinbiochem.2013.09.007","article-title":"Particle-enhanced turbidimetric immunoassay for determination of serum neutrophil gelatinase-associated lipocalin on the Roche Cobas c501 analyzer","volume":"46","author":"Xiang","year":"2013","journal-title":"Clin Biochem"},{"key":"2022050518545356200_jfab167-B44","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/jcla.21962","article-title":"Comparison of two methods for determination of NGAL levels in urine: ELISA and CMIA","volume":"30","author":"Krzeminska","year":"2016","journal-title":"J Clin Lab Anal"},{"key":"2022050518545356200_jfab167-B45","year":"2015"},{"key":"2022050518545356200_jfab167-B46"},{"key":"2022050518545356200_jfab167-B47"},{"key":"2022050518545356200_jfab167-B48","doi-asserted-by":"crossref","first-page":"030502","DOI":"10.11613\/BM.2017.030502","article-title":"Minimum requirements for the estimation of measurement uncertainty: recommendations of the joint Working group for uncertainty of measurement of the CSMBLM and CCMB","volume":"27","author":"\u0106elap","year":"2017","journal-title":"Biochem Med"},{"key":"2022050518545356200_jfab167-B49","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2022050518545356200_jfab167-B50","first-page":"1","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"3","year":"2013","journal-title":"Kidney Int"},{"key":"2022050518545356200_jfab167-B51","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.cca.2012.05.010","article-title":"Immunoassays distinguishing between HNL\/NGAL released in urine from kidney epithelial cells and neutrophils","volume":"413","author":"Xu","year":"2012","journal-title":"Clin Chim Acta"},{"key":"2022050518545356200_jfab167-B52","first-page":"SA-PO820","article-title":"Immunochemical determination of monomer, homodimer and total Neutrophil gelatinase-associated lipocalin","volume":"23","author":"Bangert","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2022050518545356200_jfab167-B53","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/ki.2012.195","article-title":"Monomeric NGAL is associated with tubulointerstitial damage in chronic kidney disease","volume":"82","author":"Nickolas","year":"2012","journal-title":"Kidney Int"},{"key":"2022050518545356200_jfab167-B54","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000443846","article-title":"Plasma neutrophil gelatinase-associated lipocalin reflects both inflammation and kidney function in patients with myocardial infarction","volume":"6","author":"Lindberg","year":"2016","journal-title":"Cardiorenal Med"}],"container-title":["The Journal of Applied Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jalm\/advance-article-pdf\/doi\/10.1093\/jalm\/jfab167\/42077640\/jfab167.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jalm\/article-pdf\/7\/3\/747\/43541666\/jfab167.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jalm\/article-pdf\/7\/3\/747\/43541666\/jfab167.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T19:51:58Z","timestamp":1651780318000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jalm\/article\/7\/3\/747\/6498037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,5]]},"references-count":54,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,1,5]]},"published-print":{"date-parts":[[2022,5,4]]}},"URL":"https:\/\/doi.org\/10.1093\/jalm\/jfab167","relation":{},"ISSN":["2576-9456","2475-7241"],"issn-type":[{"value":"2576-9456","type":"print"},{"value":"2475-7241","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,5,1]]},"published":{"date-parts":[[2022,1,5]]}}}